Headlines about BIO-key International (NASDAQ:BKYI) have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. BIO-key International earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 47.3400115424342 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of BIO-key International (NASDAQ:BKYI) traded down $0.07 on Tuesday, reaching $1.40. The company had a trading volume of 43,700 shares, compared to its average volume of 12,595. BIO-key International has a 52 week low of $1.20 and a 52 week high of $3.67.
BIO-key International (NASDAQ:BKYI) last issued its earnings results on Tuesday, November 14th. The technology company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The business had revenue of $0.94 million for the quarter. BIO-key International had a negative net margin of 106.55% and a negative return on equity of 37.54%.
In other BIO-key International news, insider Fong Wong Kwok bought 427,778 shares of the firm’s stock in a transaction that occurred on Friday, September 22nd. The shares were bought at an average price of $3.60 per share, with a total value of $1,540,000.80. Following the purchase, the insider now owns 1,781,815 shares of the company’s stock, valued at $6,414,534. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.40% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “BIO-key International (BKYI) Receives Daily News Sentiment Rating of 0.08” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/05/bio-key-international-bkyi-receives-daily-news-sentiment-rating-of-0-08.html.
About BIO-key International
BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.
Receive News & Ratings for BIO-key International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.